|Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data|
TP Van Boeckel, S Gandra, A Ashok, Q Caudron, BT Grenfell, SA Levin, ...
The Lancet infectious diseases 14 (8), 742-750, 2014
|Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis|
E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ...
The Lancet Infectious Diseases 18 (3), 318-327, 2018
|Global increase and geographic convergence in antibiotic consumption between 2000 and 2015|
EY Klein, TP Van Boeckel, EM Martinez, S Pant, S Gandra, SA Levin, ...
Proceedings of the National Academy of Sciences 115 (15), E3463-E3470, 2018
|The state of the world's antibiotics 2015|
H Gelband, P Molly Miller, S Pant, S Gandra, J Levinson, D Barter, ...
Wound healing southern africa 8 (2), 30-34, 2015
|Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study|
A Teillant, S Gandra, D Barter, DJ Morgan, R Laxminarayan
The Lancet infectious diseases 15 (12), 1429-1437, 2015
|Economic burden of antibiotic resistance: how much do we really know?|
S Gandra, DM Barter, R Laxminarayan
Clinical microbiology and infection 20 (10), 973-980, 2014
|Anthropological and socioeconomic factors contributing to global antimicrobial resistance: a univariate and multivariable analysis|
P Collignon, JJ Beggs, TR Walsh, S Gandra, R Laxminarayan
The Lancet Planetary Health 2 (9), e398-e405, 2018
|Surveillance for control of antimicrobial resistance|
E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ...
The Lancet Infectious Diseases 18 (3), e99-e106, 2018
|Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe|
M Sharland, C Pulcini, S Harbarth, M Zeng, S Gandra, S Mathur, ...
The Lancet Infectious Diseases 18 (1), 18-20, 2018
|Trends in antibiotic resistance among major bacterial pathogens isolated from blood cultures tested at a large private laboratory network in India, 2008–2014|
S Gandra, N Mojica, EY Klein, A Ashok, V Nerurkar, M Kumari, U Ramesh, ...
International Journal of Infectious Diseases 50, 75-82, 2016
|Developing core elements and checklist items for global hospital antimicrobial stewardship programmes: a consensus approach|
C Pulcini, F Binda, AS Lamkang, A Trett, E Charani, DA Goff, S Harbarth, ...
Clinical Microbiology and Infection 25 (1), 20-25, 2019
|Carbapenem-resistant enterobacteriaceae in children, United States, 1999–2012|
LK Logan, JP Renschler, S Gandra, RA Weinstein, R Laxminarayan, ...
Emerging infectious diseases 21 (11), 2014, 2015
|Questionable effectiveness of the QuantiFERON-TB Gold Test (Cellestis) as a screening tool in healthcare workers|
S Gandra, WS Scott, V Somaraju, H Wang, S Wilton, M Feigenbaum
University of Illinois at Chicago, 2010
|Scoping report on antimicrobial resistance in India|
S Gandra, J Joshi, A Trett, AL Sankhil, R Laxminarayan
Center for Disease Dynamis, Economics & Policy, 2017
|Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa in Children, United States, 1999–2012|
LK Logan, S Gandra, S Mandal, EY Klein, J Levinson, RA Weinstein, ...
Journal of the Pediatric Infectious Diseases Society 6 (4), 352-359, 2017
|Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients|
S Gandra, CM Barysauskas, DA Mack, B Barton, R Finberg, RT Ellison III
Journal of Hospital Infection 88 (3), 170-176, 2014
|Poverty and prevalence of antimicrobial resistance in invasive isolates|
G Alvarez-Uria, S Gandra, R Laxminarayan
International Journal of Infectious Diseases 52, 59-61, 2016
|The mortality burden of multidrug-resistant pathogens in India: a retrospective, observational study|
S Gandra, KK Tseng, A Arora, B Bhowmik, ML Robinson, B Panigrahi, ...
Clinical Infectious Diseases 69 (4), 563-570, 2019
|The selection and use of essential medicines: report of the WHO Expert Committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th Model List of …|
World Health Organization
World Health Organization, 2017
|Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae|
G Alvarez-Uria, S Gandra, S Mandal, R Laxminarayan
International Journal of Infectious Diseases 68, 50-53, 2018